The strength of girl cadets in the NCC has risen to 40 per cent and a phase-wise expansion has been planned for the Corps in the next few years, senior officials said on Friday. At a press ...
It was found that glepaglutide, a long-acting GLP-2 analogue, when given twice weekly as subcutaneous delivery via auto-injector in SBS patients met the primary endpoint in the EASE 1 phase 3 trial.
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...
NEW YORK, January 02, 2025 -- ( BUSINESS WIRE )-- One Equity Partners ("OEP"), a middle market private equity firm, today announced that it has completed an investment in EthosEnergy, a global ...